Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEG Studies of Sevoflurane and Ketamine Anesthesia
NCT03503578Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sevoflurane, ketamine in general anesthesia, sponsored by Massachusetts General Hospital. Started May 2018; status: completed.
02
Drugs
sevofluraneketamine
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT03503578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03503578.